Skip to main content
Erschienen in: Journal of Neurology 1/2019

11.10.2018 | Original Communication

High-sensitivity cardiac troponin T and severity of cerebral white matter lesions in patients with acute ischemic stroke

verfasst von: Regina von Rennenberg, Bob Siegerink, Ramanan Ganeshan, Kersten Villringer, Wolfram Doehner, Heinrich J. Audebert, Matthias Endres, Christian H. Nolte, Jan F. Scheitz

Erschienen in: Journal of Neurology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Cardiac troponin (hs-cTnT) is a sensitive marker of myocardial injury and has been linked to incident dementia. The underlying mechanism of that observation is still unknown. Given that severity of cerebral small vessel disease is a predictor of cognitive decline, we aimed to explore whether there is an association between hs-cTnT and severity of white matter lesions (WML) as a marker of cerebral small vessel disease in patients with ischemic stroke.

Methods

We analyzed consecutive acute ischemic stroke patients admitted to Charité-University Hospital, Berlin from 2011 to 2013. Severity of WML was graded on 3T-MRI using the age-related white matter severity score (ARWMS). Patients with hs-cTnT elevation suggestive of acute coronary syndrome (ACS) were excluded (hs-cTnT > 52 ng/l or dynamic change of hs-cTnT > 50%, ESC guideline). We performed unadjusted and adjusted quantile regression models to assess the association between increased hs-cTnT (dichotomized at the 99th percentile, 14 ng/l) and severity of WML.

Results

A total of 860 patients was analyzed (median age 73 years, 44.8% female, median ARWMS 6). Patients with elevated hs-cTnT had more extensive WML than those without (median ARWMS 8 vs. 5, adjusted beta for 50th percentile 1.12, 95% CI 0.41–1.84). The association between WML and hs-cTnT elevation was strongest in patients with severe WML (adjusted beta 1.77, 95% CI 0.26–3.27 for 80th WML percentile).

Conclusion

Elevated hs-cTnT levels were associated with extent of WML in acute stroke patients. Further studies are needed to assess whether hs-cTnT can be used to identify stroke patients at risk for cognitive decline.
Literatur
1.
Zurück zum Zitat Twerenbold R, Boeddinghaus J, Nestelberger T et al (2018) How to best use high-sensitivity cardiac troponin in patients with suspected myocardial infarction. Clin Biochem 53:143–155 CrossRefPubMed Twerenbold R, Boeddinghaus J, Nestelberger T et al (2018) How to best use high-sensitivity cardiac troponin in patients with suspected myocardial infarction. Clin Biochem 53:143–155 CrossRefPubMed
2.
Zurück zum Zitat Lee GR, Jhanji S, Tarrant H, James S, Pearse RM, Fitzgibbon M (2014) Peri-operative troponin monitoring using a prototype high-sensitivity cardiac troponin I (hs-cTnI) assay: comparisons with hs-cTnT and contemporary cTnI assays. Ann Clin Biochem 51(2):258–268CrossRefPubMed Lee GR, Jhanji S, Tarrant H, James S, Pearse RM, Fitzgibbon M (2014) Peri-operative troponin monitoring using a prototype high-sensitivity cardiac troponin I (hs-cTnI) assay: comparisons with hs-cTnT and contemporary cTnI assays. Ann Clin Biochem 51(2):258–268CrossRefPubMed
3.
Zurück zum Zitat Wijsman LW, de Craen AJ, Trompet S et al (2016) High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk. Eur J Prev Cardiol 23(13):1383–1392CrossRefPubMed Wijsman LW, de Craen AJ, Trompet S et al (2016) High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk. Eur J Prev Cardiol 23(13):1383–1392CrossRefPubMed
4.
Zurück zum Zitat Schneider AL, Rawlings AM, Sharrett AR (2014) High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study. Eur Heart J 35(27):1817–1824CrossRefPubMedPubMedCentral Schneider AL, Rawlings AM, Sharrett AR (2014) High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study. Eur Heart J 35(27):1817–1824CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Debette S, Markus HS (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341:c3666CrossRefPubMedPubMedCentral Debette S, Markus HS (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341:c3666CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat de Groot M, Verhaaren BF, de Boer R et al (2013) Changes in normal-appearing white matter precede development of white matter lesions. Stroke 44(4):1037–1042CrossRefPubMed de Groot M, Verhaaren BF, de Boer R et al (2013) Changes in normal-appearing white matter precede development of white matter lesions. Stroke 44(4):1037–1042CrossRefPubMed
7.
Zurück zum Zitat Schmidt R, Ropele S, Enzinger C et al (2005) White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 58(4):610–616CrossRefPubMed Schmidt R, Ropele S, Enzinger C et al (2005) White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 58(4):610–616CrossRefPubMed
8.
Zurück zum Zitat Knopman DS, Griswold ME, Lirette ST et al (2015) Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study. Stroke 46(2):433–440CrossRefPubMedPubMedCentral Knopman DS, Griswold ME, Lirette ST et al (2015) Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study. Stroke 46(2):433–440CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Kloppenborg RP, Nederkoorn PJ, Geerlings MI, van den Berg E (2014) Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology 82(23):2127–2138CrossRefPubMed Kloppenborg RP, Nederkoorn PJ, Geerlings MI, van den Berg E (2014) Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology 82(23):2127–2138CrossRefPubMed
10.
Zurück zum Zitat Schmidt R, Berghold A, Jokinen H et al (2012) White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke 43(10):2643–2647CrossRefPubMed Schmidt R, Berghold A, Jokinen H et al (2012) White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke 43(10):2643–2647CrossRefPubMed
11.
Zurück zum Zitat Kliper E, Ben Assayag E, Tarrasch R et al (2014) Cognitive state following stroke: the predominant role of preexisting white matter lesions. PLoS One 9(8):e105461CrossRefPubMedPubMedCentral Kliper E, Ben Assayag E, Tarrasch R et al (2014) Cognitive state following stroke: the predominant role of preexisting white matter lesions. PLoS One 9(8):e105461CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Leonards CO, Ipsen N, Malzahn U, Fiebach JB, Endres M, Ebinger M (2012) White matter lesion severity in mild acute ischemic stroke patients and functional outcome after 1 year. Stroke 43(11):3046–3051CrossRefPubMed Leonards CO, Ipsen N, Malzahn U, Fiebach JB, Endres M, Ebinger M (2012) White matter lesion severity in mild acute ischemic stroke patients and functional outcome after 1 year. Stroke 43(11):3046–3051CrossRefPubMed
13.
Zurück zum Zitat van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2008) Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39(10):2712–2719CrossRefPubMed van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2008) Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39(10):2712–2719CrossRefPubMed
14.
Zurück zum Zitat Rozanski M, Richter TB, Grittner U, Endres M, Fiebach JB, Jungehulsing GJ (2014) Elevated levels of hemoglobin A1c are associated with cerebral white matter disease in patients with stroke. Stroke 45(4):1007–1011CrossRefPubMed Rozanski M, Richter TB, Grittner U, Endres M, Fiebach JB, Jungehulsing GJ (2014) Elevated levels of hemoglobin A1c are associated with cerebral white matter disease in patients with stroke. Stroke 45(4):1007–1011CrossRefPubMed
15.
Zurück zum Zitat Savva GM, Stephan BC, Alzheimer’s Society Vascular Dementia Systematic Review Group (2010) Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 41(1):e41–e46CrossRefPubMed Savva GM, Stephan BC, Alzheimer’s Society Vascular Dementia Systematic Review Group (2010) Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 41(1):e41–e46CrossRefPubMed
16.
Zurück zum Zitat Kumar S, Selim MH, Caplan LR (2010) Medical complications after stroke. Lancet Neurol 9(1):105–118CrossRefPubMed Kumar S, Selim MH, Caplan LR (2010) Medical complications after stroke. Lancet Neurol 9(1):105–118CrossRefPubMed
17.
Zurück zum Zitat Scheitz JF, Mochmann HC, Nolte CH et al (2011) Troponin elevation in acute ischemic stroke (TRELAS)—protocol of a prospective observational trial. BMC Neurol 11:98CrossRefPubMedPubMedCentral Scheitz JF, Mochmann HC, Nolte CH et al (2011) Troponin elevation in acute ischemic stroke (TRELAS)—protocol of a prospective observational trial. BMC Neurol 11:98CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Scheitz JF, Nolte CH, Laufs U, Endres M (2015) Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke. Stroke 46(4):1132–1140CrossRefPubMed Scheitz JF, Nolte CH, Laufs U, Endres M (2015) Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke. Stroke 46(4):1132–1140CrossRefPubMed
19.
Zurück zum Zitat Wahlund LO, Barkhof F, Fazekas F et al (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32(6):1318–1322CrossRefPubMed Wahlund LO, Barkhof F, Fazekas F et al (2001) A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32(6):1318–1322CrossRefPubMed
21.
Zurück zum Zitat Beyerlein A (2014) Quantile regression—opportunities and challenges from a user’s perspective. Am J Epidemiol 180(3):330–331CrossRefPubMed Beyerlein A (2014) Quantile regression—opportunities and challenges from a user’s perspective. Am J Epidemiol 180(3):330–331CrossRefPubMed
22.
Zurück zum Zitat Hilal S, Chai YL, van Veluw S et al (2017) Association between subclinical cardiac biomarkers and clinically manifest cardiac diseases with cortical cerebral microinfarcts. JAMA Neurol 74(4):403–410CrossRefPubMedPubMedCentral Hilal S, Chai YL, van Veluw S et al (2017) Association between subclinical cardiac biomarkers and clinically manifest cardiac diseases with cortical cerebral microinfarcts. JAMA Neurol 74(4):403–410CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Dadu RT, Fornage M, Virani SS et al (2013) Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke 44(7):1803–1808CrossRefPubMedPubMedCentral Dadu RT, Fornage M, Virani SS et al (2013) Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke 44(7):1803–1808CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Zonneveld HI, Ikram MA, Hofman A et al (2017) N-Terminal pro-B-type natriuretic peptide and subclinical brain damage in the general population. Radiology 283(1):205–214CrossRefPubMed Zonneveld HI, Ikram MA, Hofman A et al (2017) N-Terminal pro-B-type natriuretic peptide and subclinical brain damage in the general population. Radiology 283(1):205–214CrossRefPubMed
25.
Zurück zum Zitat Russo C, Jin Z, Liu R et al (2013) LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study. JACC Cardiovasc Imag 6(3):313–323CrossRef Russo C, Jin Z, Liu R et al (2013) LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study. JACC Cardiovasc Imag 6(3):313–323CrossRef
26.
Zurück zum Zitat Russo C, Jin Z, Homma S et al (2013) Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study. Circulation 128(10):1105CrossRefPubMedPubMedCentral Russo C, Jin Z, Homma S et al (2013) Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study. Circulation 128(10):1105CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Gouw AA, van der Flier WM, van Straaten EC et al (2008) Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis 25(3):247–253CrossRefPubMed Gouw AA, van der Flier WM, van Straaten EC et al (2008) Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis 25(3):247–253CrossRefPubMed
28.
Zurück zum Zitat Nolte CH, Endres M (2014) The heart of the matter: a link between troponin and dementia? Eur Heart J 35(27):1779–1781CrossRefPubMed Nolte CH, Endres M (2014) The heart of the matter: a link between troponin and dementia? Eur Heart J 35(27):1779–1781CrossRefPubMed
29.
Zurück zum Zitat Saunders JT, Nambi V, de Lemos JA et al (2011) Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 123(13):1367–1376CrossRefPubMedPubMedCentral Saunders JT, Nambi V, de Lemos JA et al (2011) Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 123(13):1367–1376CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Kim BJ, Lee SH, Kim CK et al (2011) Advanced coronary artery calcification and cerebral small vessel diseases in the healthy elderly. Circ J 75(2):451–456CrossRefPubMed Kim BJ, Lee SH, Kim CK et al (2011) Advanced coronary artery calcification and cerebral small vessel diseases in the healthy elderly. Circ J 75(2):451–456CrossRefPubMed
31.
Zurück zum Zitat Willeit K (2014) Atherosclerosis and atrial fibrillation—two closely intertwined diseases. Atherosclerosis 233:679–681CrossRefPubMed Willeit K (2014) Atherosclerosis and atrial fibrillation—two closely intertwined diseases. Atherosclerosis 233:679–681CrossRefPubMed
32.
Zurück zum Zitat Adameova D (2014) Role of microangiopathy in diabetic cardiomyopathy. Heart Fail Rev 19:25–33CrossRefPubMed Adameova D (2014) Role of microangiopathy in diabetic cardiomyopathy. Heart Fail Rev 19:25–33CrossRefPubMed
33.
Zurück zum Zitat de la Torre JC (2012) Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol 2012:367516PubMedPubMedCentral de la Torre JC (2012) Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol 2012:367516PubMedPubMedCentral
34.
Zurück zum Zitat Psaty BM, Manolio TA, Kuller LH et al (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96(7):2455–2461CrossRefPubMed Psaty BM, Manolio TA, Kuller LH et al (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96(7):2455–2461CrossRefPubMed
35.
Zurück zum Zitat Krause T, Werner K, Fiebach JB et al (2017) Stroke in right dorsal anterior insular cortex is related to myocardial injury. Ann Neurol 81(4):502–511CrossRefPubMed Krause T, Werner K, Fiebach JB et al (2017) Stroke in right dorsal anterior insular cortex is related to myocardial injury. Ann Neurol 81(4):502–511CrossRefPubMed
36.
Zurück zum Zitat Omland T, Røsjø H, Giannitsis E, Agewall S (2015) Troponins in heart failure. Clin Chim Acta 443:78–84CrossRefPubMed Omland T, Røsjø H, Giannitsis E, Agewall S (2015) Troponins in heart failure. Clin Chim Acta 443:78–84CrossRefPubMed
37.
Zurück zum Zitat Cannon JA, Moffitt P, Perez-Moreno AC et al (2017) Cognitive impairment and heart failure: systematic review and meta-analysis. J Card Fail 23(6):464–475CrossRefPubMed Cannon JA, Moffitt P, Perez-Moreno AC et al (2017) Cognitive impairment and heart failure: systematic review and meta-analysis. J Card Fail 23(6):464–475CrossRefPubMed
Metadaten
Titel
High-sensitivity cardiac troponin T and severity of cerebral white matter lesions in patients with acute ischemic stroke
verfasst von
Regina von Rennenberg
Bob Siegerink
Ramanan Ganeshan
Kersten Villringer
Wolfram Doehner
Heinrich J. Audebert
Matthias Endres
Christian H. Nolte
Jan F. Scheitz
Publikationsdatum
11.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 1/2019
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-9085-3

Weitere Artikel der Ausgabe 1/2019

Journal of Neurology 1/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.